What We Do

Close-up of a lightbulb glowing with branching points of light inside it, overlaid with horizontal bars and circular geometric shapes

Advancing pharmacy practice through evidence-based research

We conduct meaningful research. From demonstrating the impact of pharmacists on patient and population health outcomes to promoting the expanded scope of pharmacists in community-based settings, our team conducts research that informs real-world pharmacy practice advancement in partnership with multiple state-level stakeholders across different settings.

News

dave dixon

Dec. 19, 2025

VCU Pharmacy faculty help shape ADA’s 2026 Standards of Care in Diabetes

Recommendations from Dr. Dave Dixon focus on addressing and preventing cardiovascular disease, the leading cause of death among people with diabetes.

Rana Amayreh stands with V C U pharmacy faculty and advisors after defending dissertation

Dec. 17, 2025

Ph.D. student’s work aims to expand pharmacist clinical services in Virginia

Class of 2025 Rana Amayreh has developed a resource focused on increasing uptake of statewide protocols and Medicaid billing for community-based pharmacist services in Virginia.

VCU produces more graduates in health-related degrees than any other university in the state, making VCU an unparalleled leader in shaping Virginia’s health care future. (VCU School of Dentistry)

Nov. 21, 2025

Here is how VCU plays an unparalleled role in training Virginia’s health care workforce

The state’s top producer of health sciences graduates is treating the critical need for more providers.

Cover of the VCU School of Pharmacy Center for Pharmacy Practice Innovation 2024–2025 annual report, with the tagline “Helping pharmacists optimize patient outcomes”

Discover CPPI’s 2024-25 Impact

From tackling pharmacy deserts to advancing pharmacist roles in patient care, our work this year has driven innovation, collaboration and improved health outcomes across Virginia and beyond. Explore the stories, research and milestones that shaped our mission in the 2024-25 Annual Report.